Evidence map›Paper›PMID 35433162›Full record

ArticleBioscience of microbiota, food and health2022

Masateru Yamamoto, Hiromitsu Ohmori, Daisuke Takei, Tomio Matsumoto, Masahiko Takemoto, Masanobu Ikeda, Ryo Sumimoto, Tsuyoshi Kobayashi, Hideki Ohdan

Open access · diamondAbstract read
In one paragraph

Article in Bioscience of microbiota, food and health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. The effects of different doses ofVeterinary and animal science · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Animals : an open access journal from MDPI · 2024
    Article
  7. Article
  8. Observational
  9. Effects ofInternational journal of molecular sciences · 2023
    Article
  10. Effects of dietaryFrontiers in immunology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Masateru YamamotoDepartment of Surgery, National Hospital Organization Yanai Medical Center, 95 Ihonoshou, Yanai-shi, Yamaguchi 742-1352, Japan.
Hiromitsu OhmoriDepartment of Pediatrics, National Hospital Organization Yanai Medical Center, 95 Ihonoshou, Yanai-shi, Yamaguchi 742-1352, Japan.
Daisuke TakeiDepartment of Surgery, National Hospital Organization Yanai Medical Center, 95 Ihonoshou, Yanai-shi, Yamaguchi 742-1352, Japan.
Tomio MatsumotoDepartment of Surgery, National Hospital Organization Yanai Medical Center, 95 Ihonoshou, Yanai-shi, Yamaguchi 742-1352, Japan.
Masahiko TakemotoDepartment of Surgery, National Hospital Organization Yanai Medical Center, 95 Ihonoshou, Yanai-shi, Yamaguchi 742-1352, Japan.
Masanobu IkedaDepartment of Surgery, National Hospital Organization Yanai Medical Center, 95 Ihonoshou, Yanai-shi, Yamaguchi 742-1352, Japan.
Ryo SumimotoDepartment of Surgery, National Hospital Organization Yanai Medical Center, 95 Ihonoshou, Yanai-shi, Yamaguchi 742-1352, Japan.
Tsuyoshi KobayashiDepartment of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima 734-8551, Japan.
Hideki OhdanDepartment of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima City, Hiroshima 734-8551, Japan.
National Hospital Organization · JPHiroshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut microbiota has nutritional and protective functions. In patients with end-stage renal disease, changes in the gut microbiota disrupt their protective functions. Probiotics help maintain normal bowel function. However, their role in patients with end-stage renal disease is controversial. We investigated whether

Indexed as

16S rDNAClostridium butyricumend stage renal diseasegut microbiotahemodialysis

Identifiers

PMID35433162
PMCPMC8970657
OpenAlexW3206236086

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.